The White House has issued an Executive Order directing federal agencies to accelerate research and streamline approvals for psychedelic-based...

Oculis has completed the final patient visit in both Phase 3 DIAMOND trials evaluating OCS-01, a high-concentration dexamethasone eye...

Amneal reported positive interim results from its open-label Phase 4 ELEVATE-PD study showing that patients switching to CREXONT, a...

Medtronic's strategic investment in Pulnovo Medical's oversubscribed $100M round signals a quiet land grab in pulmonary hypertension and heart...

Nanobiotix presented new preclinical data at AACR showing that an intravenous “nanoprimer” administered before lipid nanoparticle–delivered recombinant DNA increased...

Nxera Pharma has reached a third R&D milestone in its multi-target neurology discovery collaboration with AbbVie, triggering a $10...

Achieve Life Sciences has secured up to $354 million to carry its nicotine-dependence franchise through a pivotal inflection point,...

Aligos Therapeutics has licensed Greater China rights to its oral HBV capsid assembly modulator, pevifoscorvir sodium (ALG-000184), to Xiamen...

Eurobio Scientific has signed a definitive agreement to acquire CareDx’s Lab Products division for approximately €145 million in cash,...

BioVersys has dosed the first patient in its global pivotal Phase 3 RIV-TARGET trial evaluating BV100, an intravenous rifabutin...